# Merck & Co Inc – FDA Inspection, Sep 1, 2023

Source: https://www.keypedia.com/records/fda_inspections/merck-co-inc/b19cee79-d8b2-45a8-848e-1271b06602e6
Source feed: FDA_Inspections

> FDA inspection 1219020 of Merck & Co Inc, September 01, 2023. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1219020
- Company Name: Merck & Co Inc
- Inspection Date: 2023-09-01
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1071196 - 2018-11-01
- [FDA Inspection 988466 - 2016-09-20](https://www.keypedia.com/records/fda_inspections/merck-co-inc/d94aa913-b79d-4b41-93df-116c588a5faf)
- [FDA Inspection 970042 - 2016-04-12](https://www.keypedia.com/records/fda_inspections/merck-co-inc/d1f4982a-0958-42be-9e68-10f1ff0457f9)
- [FDA Inspection 849685 - 2013-10-08](https://www.keypedia.com/records/fda_inspections/merck-co-inc/fbd90269-09c5-47f2-a866-de31e5ac3c10)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/gabrielle-j-swain/55f33430-41dc-4fae-bac0-ec6ea340feb6)

Company: https://www.keypedia.com/companies/merck-co-inc/b31c98fd-1c55-4600-8977-5abbfb1991f5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
